OPPENHEIMER ASSET MANAGEMENT INC.

Position in EBS — Emergent BioSolutions Inc.

CIK 1269119 NEW YORK, NY

Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$265,201

-$862,358 QoQ

Shares Held

31,647

-12.9% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#88

of 193 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $29,360,494 across 8 Drug Manufacturers - Specialty & Generic names. EBS ranks #8 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	17,725	$9,603,935
2	ZTS	Zoetis Inc.	100,377	$7,213,089
3	HLN	Haleon plc	512,009	$4,777,043
4	LNTH	Lantheus Holdings, Inc.	22,842	$2,534,091
5	NBIX	Neurocrine Biosciences Inc	14,783	$2,491,525
6	VTRS	Viatris Inc	91,463	$1,452,432
7	TAK	Takeda Pharmaceutical Co Ltd	63,829	$1,023,178
8	EBS	Emergent BioSolutions Inc. This page	31,647	$265,201

All Filings in EBS

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$265,201	31,647	-12.9%	Shares	Other	2026-08-03
2022-06-30	$1,127,559	36,326	-3.3%	Shares	Other	2022-08-08
2022-03-31	$1,542,377	37,564	+12.7%	Shares	Other	2022-05-12
2021-12-31	$1,449,202	33,338	-9.5%	Shares	Other	2022-02-02
2021-09-30	$1,844,178	36,832	+0.5%	Shares	Other	2021-11-12
2021-06-30	$2,309,465	36,664	+36.9%	Shares	Other	2021-08-03
2021-03-31	$2,487,478	26,773	+9.1%	Shares	Other	2021-05-17
2020-12-31	$2,198,424	24,536	+0.1%	Shares	Other	2021-02-11
2020-09-30	$2,532,410	24,508	-47.9%	Shares	Other	2020-11-13
2020-06-30	$3,717,867	47,014	+16.3%	Shares	Other	2020-08-11
2020-03-31	$2,338,006	40,408	—	Shares	Other	2020-05-08
No filing history on record for this holder in this stock.